Stay updated on Elafibranor in NASH: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elafibranor in NASH: Efficacy & Safety Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.7.0, marking a recent update to the ClinicalTrials.gov page. This indicates a structural or presentation update rather than changes to the study data.
    Difference
    16%
    Check dated 2026-09-20T19:25:50.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's text remains unchanged. There are no additions or deletions to report.
    Difference
    0.0%
    Check dated 2026-09-06T22:21:10.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added the U.S. NIH grant/contract identifier under Other Study ID Numbers to clarify funding provenance for the study. Updated the page revision to v3.6.6, replacing the previous v3.6.5 entry to reflect a new version of the page.
    Difference
    0.0%
    Check dated 2026-08-30T21:51:09.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's versioning. The substantive content and study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-08-09T12:29:34.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4. This appears to be a small software update with no changes to content or visible features.
    Difference
    0.0%
    Check dated 2026-07-26T00:17:33.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The glossary/MeSH term Fatty Liver Disease has been updated to Steatotic Liver Disease. This change aligns terminology with current classifications and affects indexing rather than the study data.
    Difference
    0.0%
    Check dated 2026-07-18T20:42:03.000Z thumbnail image

Stay in the know with updates to Elafibranor in NASH: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.